Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 761,407 | 675,040 | 482,375 | 401,858 | 365,978 |
| Cost of Goods | 12,977 | 10,882 | 6,481 | 5,385 | 5,281 |
| Gross Profit | 748,430 | 664,158 | 475,894 | 396,473 | 360,697 |
| Operating Expenses | 704,610 | 528,089 | 369,093 | 284,224 | 236,501 |
| Operating Income | 44,797 | 136,951 | 107,282 | 112,634 | 124,477 |
| Other Income | 21,666 | 24,542 | 17,275 | 3,557 | 529 |
| Pre-tax Income | 66,463 | 161,493 | 124,557 | 116,191 | 125,006 |
| Income Tax | -33,189 | 20,284 | 18,417 | 14,773 | 12,494 |
| Net Income Continuous | 99,652 | 141,209 | 106,140 | 101,418 | 112,512 |
| Net Income | $99,652 | $141,209 | $106,140 | $101,418 | $112,512 |
| EPS Basic Total Ops | 0.95 | 1.35 | 1.02 | 0.95 | 0.97 |
| EPS Basic Continuous Ops | 0.96 | 1.37 | 1.02 | 0.95 | 0.97 |
| EPS Diluted Total Ops | 0.82 | 1.23 | 0.94 | 0.87 | 0.89 |
| EPS Diluted Continuous Ops | 0.83 | 1.24 | 0.95 | 0.87 | 0.89 |
| EPS Diluted Before Non-Recurring Items | 0.82 | 1.23 | 0.94 | 0.87 | 0.89 |
| EBITDA(a) | $41,584 | $127,349 | $100,516 | $117,463 | $133,036 |